Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2009

01.11.2009 | Original Article

Over-Expression of EphA2 and EphrinA-1 in Human Gastric Adenocarcinoma and Its Prognostic Value for Postoperative Patients

verfasst von: Wei-Jie Yuan, Jie Ge, Zhi-Kang Chen, Shao-Bin Wu, Hong Shen, Pu Yang, Bin Hu, Ge-Wen Zhang, Zi-Hua Chen

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2009

Einloggen, um Zugang zu erhalten

Abstract

This study aims to investigate the expression and significance of EphA2 and EphrinA-1 in human gastric adenocarcinoma progression and prognosis. The expression of EphA2 and EphrinA-1 was detected in the cell lines and tissues of gastric adenocarcinoma. Different expression levels of EphA2 and EphrinA-1 were found in two cell lines. The expression of EphA2 and EphrinA-1 was significantly higher in gastric adenocarcinoma tissues than in normal tissues. Statistical analysis showed a significant correlation of EphA2 expression with the depth of tumor invasion, tumor-node-metastasis (TNM) stages, and lymph node metastasis. EphrinA-1 over-expression was significantly correlated with TNM stages and lymph node metastasis, while EphA2 expression was found to be an independent prognostic factor of postoperative gastric adenocarcinoma. In conclusion, the increased expression of EphA2 and EphrinA-1 plays an important role in the progression of human gastric adenocarcinoma, in which elevated EphA2 expression is an independent factor that indicates poor prognosis in postoperative gastric adenocarcinoma.
Literatur
7.
Zurück zum Zitat Zelinski DP, Zantek ND, Stewart JC, et al. EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res, 2001;61:2301–2306.PubMed Zelinski DP, Zantek ND, Stewart JC, et al. EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res, 2001;61:2301–2306.PubMed
8.
Zurück zum Zitat Kinch MS, Moore MB, Harpole DH Jr. Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. Clin Cancer Res, 2003;9:613–618.PubMed Kinch MS, Moore MB, Harpole DH Jr. Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. Clin Cancer Res, 2003;9:613–618.PubMed
10.
Zurück zum Zitat Xu F, Zhong W, Li J, et al. Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma. Anticancer Res, 2005;25:2943–2950.PubMed Xu F, Zhong W, Li J, et al. Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma. Anticancer Res, 2005;25:2943–2950.PubMed
13.
Zurück zum Zitat Barranco SC, Townsend CM Jr, Casartelli C, et al. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res, 1983;43:1703–1709.PubMed Barranco SC, Townsend CM Jr, Casartelli C, et al. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res, 1983;43:1703–1709.PubMed
14.
Zurück zum Zitat Lin CH, Fu ZM, Liu YL, et al. Investigation of SGC-7901 cell line established from human gastric carcinoma cells. Chin Med J, 1984;97:831–834.PubMed Lin CH, Fu ZM, Liu YL, et al. Investigation of SGC-7901 cell line established from human gastric carcinoma cells. Chin Med J, 1984;97:831–834.PubMed
15.
Zurück zum Zitat Sobin LH, Wittekind Ch. International Union Against Cancer. TNM Classification of Malignant Tumors, 5th edn. New York: Wiley; 1997. Sobin LH, Wittekind Ch. International Union Against Cancer. TNM Classification of Malignant Tumors, 5th edn. New York: Wiley; 1997.
16.
Zurück zum Zitat Herath NI, Spanevello MD, Sabesan S, et al. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. BMC Cancer, 2006;6:144. doi:10.1186/1471-2407-6-144.CrossRefPubMed Herath NI, Spanevello MD, Sabesan S, et al. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. BMC Cancer, 2006;6:144. doi:10.​1186/​1471-2407-6-144.CrossRefPubMed
17.
20.
Zurück zum Zitat Nakamura R, Kataoka H, Sato N, et al. EPHA2/EFNA1 expression in human gastric cancer. Cancer Sci, 2005;96:42–47.PubMed Nakamura R, Kataoka H, Sato N, et al. EPHA2/EFNA1 expression in human gastric cancer. Cancer Sci, 2005;96:42–47.PubMed
22.
Zurück zum Zitat Zantek ND, Walker-Daniels J, Stewart J, et al. MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer. Clin Cancer Res, 2001;7:3640–3648.PubMed Zantek ND, Walker-Daniels J, Stewart J, et al. MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer. Clin Cancer Res, 2001;7:3640–3648.PubMed
23.
Zurück zum Zitat Walker-Daniels J, Riese DJ 2nd, Kinch MS. c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Mol Cancer Res, 2002;1:79–87.PubMed Walker-Daniels J, Riese DJ 2nd, Kinch MS. c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Mol Cancer Res, 2002;1:79–87.PubMed
28.
29.
Zurück zum Zitat Brantley-Sieders DM, Zhuang G, Hicks D, et al. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. J Clin Invest, 2008;118:64–78. doi:10.1172/JCI33154.CrossRefPubMed Brantley-Sieders DM, Zhuang G, Hicks D, et al. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. J Clin Invest, 2008;118:64–78. doi:10.​1172/​JCI33154.CrossRefPubMed
30.
Zurück zum Zitat Easty DJ, Guthrie BA, Maung K, et al. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. Cancer Res, 1995;55:2528–2532.PubMed Easty DJ, Guthrie BA, Maung K, et al. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. Cancer Res, 1995;55:2528–2532.PubMed
Metadaten
Titel
Over-Expression of EphA2 and EphrinA-1 in Human Gastric Adenocarcinoma and Its Prognostic Value for Postoperative Patients
verfasst von
Wei-Jie Yuan
Jie Ge
Zhi-Kang Chen
Shao-Bin Wu
Hong Shen
Pu Yang
Bin Hu
Ge-Wen Zhang
Zi-Hua Chen
Publikationsdatum
01.11.2009
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2009
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0649-4

Weitere Artikel der Ausgabe 11/2009

Digestive Diseases and Sciences 11/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.